医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2015年
23期
284-284
,共1页
阿托伐他汀%高脂血症
阿託伐他汀%高脂血癥
아탁벌타정%고지혈증
Atorvastatin%Hyperlipidemia
目的探讨阿托伐他汀治疗高脂血症的疗效及安全性。方法对2010~2013年在我院就诊的60例原发性高脂血症患者随机分为观察组和对照组各30例，分别给服阿托伐他汀、辛伐他汀10 mg，1次/d，疗程8 w。结果口服用药8 w后，两组血清TC、TG、LDH-C水平明显下降，HDL-C水平明显提高(<0.05)；且观察组下降幅度较对照组更加明显(<0.05)。两组均未见不良反应。结论阿托伐他汀治疗高脂血症患者降脂疗效确切，不良反应少，是可供首选的降脂药物。
目的探討阿託伐他汀治療高脂血癥的療效及安全性。方法對2010~2013年在我院就診的60例原髮性高脂血癥患者隨機分為觀察組和對照組各30例，分彆給服阿託伐他汀、辛伐他汀10 mg，1次/d，療程8 w。結果口服用藥8 w後，兩組血清TC、TG、LDH-C水平明顯下降，HDL-C水平明顯提高(<0.05)；且觀察組下降幅度較對照組更加明顯(<0.05)。兩組均未見不良反應。結論阿託伐他汀治療高脂血癥患者降脂療效確切，不良反應少，是可供首選的降脂藥物。
목적탐토아탁벌타정치료고지혈증적료효급안전성。방법대2010~2013년재아원취진적60례원발성고지혈증환자수궤분위관찰조화대조조각30례，분별급복아탁벌타정、신벌타정10 mg，1차/d，료정8 w。결과구복용약8 w후，량조혈청TC、TG、LDH-C수평명현하강，HDL-C수평명현제고(<0.05)；차관찰조하강폭도교대조조경가명현(<0.05)。량조균미견불량반응。결론아탁벌타정치료고지혈증환자강지료효학절，불량반응소，시가공수선적강지약물。
Objective To explore the curative ef ect of atorvastatin treatment of hyperlipidemia, and safety.Methods From 2010 to 2010 in our hospital of 60 patients with primary hyperlipidemia were randomly divided into observation group and control group 30 cases, to take atorvastatin and simvastatin 10 mg, 1 time/day, the course of 8 weeks.Results Oral drugs after 8 weeks, two groups of serum TC, TG, LDH-C level declined obviously, HDL-C level increased significantly ( ﹤0.05);And observation group decreased relatively more obvious than control ( ﹤ 0.05).Two groups of adverse reaction was not found.Conclusion Atorvastatin treatment of hyperlipidemia patients of lipid-lowering ef icacy, less adverse reaction, are the prefer ed lipid-lowering drugs.
